Table 2.
GAPDH- Fwd | ACTCAGTCCCCCACCACACT |
GAPDH- Rev | GGTACATGACAAGGTGCGGC |
LYS- Fwd | GCCATATCGGCTCGCAAATC |
LYS- Rev | AACGAATGCCGAAACCTCCTC |
OPRM1- Fwd | AGTGTGTTAGTTCCATCATCATGTC |
OPRM1- Rev | TCTGATCATCCTGTCCTACCTG |
OPRD1- Fwd | CGGGACCTGTGGCTCTACAA |
OPRD1- Rev | CCCCCAACTCCGAAAGTCCG |
OPRK1- Fwd | AATTCAGGGAGCACACTGGC |
OPRK1- Rev | AAATTGCCTTAAGGAAGCTGGGT |
OPRL1- Fwd | GGAAGTGATGGCTGTCTCGC |
OPRL1- Rev | GAGCCTCCCCAGAACAGTCC |
TRPV1- Fwd | TTGGGGGTGTTGGTGTTTCCT |
TRPV1- Rev | AGCAGGACTGGGGTTCCTAGA |
Forward (Fwd) and reverse (Rev) primers for glyceraldehyde 3-phosphate dehydrogenase (GAPDH), lysis protein (LYS), opioid receptor mu 1 (OPRM1), opioid receptor delta 1 (ORPD1), opioid receptor kappa (OPRK1), opioid related nociceptin receptor 1 (OPRL1), and transient receptor potential cation channel subfamily V member 1 (TRPV1).